Mylan will distribute the drug as a COVID-19 treatment in 127 low- and middle-income countries.
News & Analysis: Mylan
The COVID-19 pandemic helped the drugmaker's sales more than it hurt.
Regulators take different approaches to the unapproved medications.
An old malaria drug may unseat newer investigational coronavirus treatments -- if data is confirmed.
Pfizer's plan to merge its post-exclusivity segment with Mylan will have to wait.
No, but doctors can still use the drugs despite limited evidence of their effectiveness.
The pursuit of a COVID-19 vaccine and antiviral therapies, the Defense Production Act, and using cruise ships as makeshift hospitals were among the topics covered in the briefing.
The decades-old malaria drug could help fight the new coronavirus.
An overall market rebound and a presidential press conference carried several biotech and pharmaceutical stocks markedly higher.
MYL earnings call for the period ending December 31, 2019.